story of the week
Perioperative Durvalumab With Neoadjuvant Chemotherapy for Operable Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
N. Engl. J. Med 2024 Sep 15;[EPub Ahead of Print], T Powles, JWF Catto, MD Galsky, H Al-Ahmadie, JJ Meeks, H Nishiyama, TQ Vu, L Antonuzzo, P Wiechno, V Atduev, AG Kann, TH Kim, C Suárez, CH Chang, F Roghmann, M Özgüroğlu, BJ Eigl, N Oliveira, T Buchler, M Gadot, Y Zakharia, J Armstrong, A Gupta, S Hois, MS van der HeijdenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.